ADC THERAPEUTICS
ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.
ADC THERAPEUTICS
Industry:
Biopharma Biotechnology Medical Therapeutics
Founded:
2011-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.adctherapeutics.com
Total Employee:
251+
Status:
Active
Contact:
+1 908-731-5556
Email Addresses:
[email protected]
Total Funding:
691.55 M USD
Technology used in webpage:
Nginx Microsoft Exchange Online Amazon ReCAPTCHA Cloudflare Person Schema Cloudflare Hosting Gravatar Profiles Apple Mobile Web App Capable Cloudflare SSL
Current Advisors List


![]()
![]()
Current Employees Featured
![]()
![]()
![]()
Founder
Stock Details
Investors List
![]()
Deerfield
Deerfield investment in Post-IPO Debt - ADC Therapeutics
![]()
Deerfield
Deerfield investment in Post-IPO Debt - ADC Therapeutics
![]()
Redmile Group
Redmile Group investment in Series E - ADC Therapeutics
![]()
Auven Therapeutics
Auven Therapeutics investment in Series E - ADC Therapeutics
![]()
AstraZeneca
AstraZeneca investment in Series E - ADC Therapeutics
![]()
Redmile Group
Redmile Group investment in Series E - ADC Therapeutics
![]()
Auven Therapeutics
Auven Therapeutics investment in Series E - ADC Therapeutics
![]()
AstraZeneca
AstraZeneca investment in Series E - ADC Therapeutics
![]()
Auven Therapeutics
Auven Therapeutics investment in Series D - ADC Therapeutics
![]()
AstraZeneca
AstraZeneca investment in Series D - ADC Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-13 | ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer |
| 2022-05-09 | ADC Therapeutics Announces CEO Transition |
| 2020-04-21 | ADC Therapeutics Appoints Jennifer Creel as Chief Financial Officer |
Official Site Inspections
http://www.adctherapeutics.com Semrush global rank: 2.17 M Semrush visits lastest month: 9.11 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
